Breast Cancer

  1. Nerlynx (neratinib)
    Nerlynx (neratinib)
    by Puma biotechnology
    for Breast Cancer
    €19,200.00
  2. Verzenio/Verzenios (abemaciclib)
    Verzenio/Verzenios (abemaciclib)
    by Lilly
    for Breast Cancer
    €1,588.40
  3. Ibrance (palbociclib)
    Ibrance (palbociclib)
    by Pfizer Limited
    for Breast Cancer
    €2,880.00
  4. Kisqali (ribociclib)
    Kisqali (ribociclib)
    by Novartis Europharm Limited
    for Breast Cancer
    €2,592.00
  5. Lynparza (olaparib)
    Lynparza (olaparib)
    by AstraZeneca AB
    for Breast Cancer, Gynaecological Cancer
    €6,283.20
  6. Perjeta (pertuzumab)
    Perjeta (pertuzumab)
    by Roche Registration Limited
    for Breast Cancer
    €2,988.60
View as Grid List

6 Items

per page
Set Descending Direction